Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers

NCT06977126 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Gynecological Cancers

Interventions

DRUG: PORPHYSOMES
DRUG: 64Cu-PORPHYSOMES

Sponsor

University Health Network, Toronto